FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004733105> ?p ?o ?g. }

• W2004733105 endingPage "284" @default.
• W2004733105 startingPage "267" @default.
• W2004733105 abstract "In vitro reactivity for each of four osteolathyrogens with a model compound for the lysyl oxidase (LO) cofactor was evaluated and coupled with mixture toxicity testing to evaluate agent-cofactor reactivity as a potential mechanism of action for osteolathyrism. Reactivity of the model cofactor (mLTQ: 4-butylamino-5-methyl-o-quinone), with each of two ureides, semicarbazide (SC) and thiosemicarbazide (TSC), and each of two aminonitriles, aminoacetonitrile (AAN) and beta-aminopropionitrile (betaAPN), was assessed using UV-vis spectrophotometry; both in the absence and presence of Cu(II)-bipyridine (bipy) complex. Two sets of mixture toxicity experiments were conducted using a frog embryo assay that assessed the incidence of osteolathyrism in the notochord of tadpoles after 96-h exposure. The resulting concentration-response curves for each set were evaluated (chi(2) goodness-of-fit test) against theoretical curves for two combined effects models: dose-addition and independence, to determine the combined effect of each osteolathyrogen combination. The agents SC, TSC and AAN each showed rapid, irreversible reactivity with mLTQ, both in the absence and presence of Cu(II)-bipy complex, as indicated by bleaching of the mLTQ peak (504 nm) and formation of an adduct at 350 nm. betaAPN showed no apparent reactivity in the absence of prolonged incubation with mLTQ, whether Cu(II)-bipy complex was present or not. After prolonged incubation (24-144 h) a new peak formed at 350 nm, suggesting that betaAPN reacts weakly with the cofactor, but in a manner different from the other agents examined. The toxicity tests indicated a dose-additive combined effect for the SC:TSC, AAN:SC and AAN:SC:TSC mixtures (0.1<P<0.9; with slope and EC(50) additivity quotient values between 0.93-1.14), suggesting these agents induce osteolathyrism via a common mechanism. The betaAPN:SC and betaAPN: SC:TSC mixtures showed a greater-than dose-additive combined effect (P<0.001; slope and EC(50) additivity quotient values from 0.74 to 0.89), suggesting a different or additional mechanism of osteolathyrism for betaAPN. Taken together the results indicate that SC, TSC and AAN induce osteolathyrism primarily, if not completely, by binding to the LO cofactor, thereby inhibiting proper connective tissue fiber cross-linking. While betaAPN also has the potential to react with the cofactor, the nature of the reactivity observed suggests that betaAPN-cofactor binding is, at best, a secondary mechanism for induction of osteolathyrism in vivo." @default.
• W2004733105 created "2016-06-24" @default.
• W2004733105 creator A5025256830 @default.
• W2004733105 creator A5026845056 @default.
• W2004733105 creator A5083574960 @default.
• W2004733105 date "2002-08-01" @default.
• W2004733105 modified "2023-09-26" @default.
• W2004733105 title "Biochemical and toxicological evaluation of agent-cofactor reactivity as a mechanism of action for osteolathyrism" @default.
• W2004733105 cites W1503346702 @default.
• W2004733105 cites W1503991018 @default.
• W2004733105 cites W1516190549 @default.
• W2004733105 cites W1516816071 @default.
• W2004733105 cites W1546784202 @default.
• W2004733105 cites W1570350390 @default.
• W2004733105 cites W1826100345 @default.
• W2004733105 cites W1979098362 @default.
• W2004733105 cites W1980615360 @default.
• W2004733105 cites W1990899865 @default.
• W2004733105 cites W1992412033 @default.
• W2004733105 cites W1994993480 @default.
• W2004733105 cites W1997462891 @default.
• W2004733105 cites W2001319672 @default.
• W2004733105 cites W2005318430 @default.
• W2004733105 cites W2006253826 @default.
• W2004733105 cites W2006886748 @default.
• W2004733105 cites W2007170020 @default.
• W2004733105 cites W2017665949 @default.
• W2004733105 cites W2022102713 @default.
• W2004733105 cites W2028399273 @default.
• W2004733105 cites W2028713663 @default.
• W2004733105 cites W2034356701 @default.
• W2004733105 cites W2039724735 @default.
• W2004733105 cites W2048406204 @default.
• W2004733105 cites W2049346324 @default.
• W2004733105 cites W2057727986 @default.
• W2004733105 cites W2059196614 @default.
• W2004733105 cites W2060190127 @default.
• W2004733105 cites W2060890652 @default.
• W2004733105 cites W2062205832 @default.
• W2004733105 cites W2084935707 @default.
• W2004733105 cites W2085224134 @default.
• W2004733105 cites W2095689095 @default.
• W2004733105 cites W2097310936 @default.
• W2004733105 cites W2101171458 @default.
• W2004733105 cites W2105294527 @default.
• W2004733105 cites W2140118807 @default.
• W2004733105 cites W2170567555 @default.
• W2004733105 cites W2320917651 @default.
• W2004733105 cites W2352105346 @default.
• W2004733105 cites W2424288574 @default.
• W2004733105 cites W2985957799 @default.
• W2004733105 cites W4246724958 @default.
• W2004733105 doi "https://doi.org/10.1016/s0300-483x(02)00233-0" @default.
• W2004733105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12135629" @default.
• W2004733105 hasPublicationYear "2002" @default.
• W2004733105 type Work @default.
• W2004733105 sameAs 2004733105 @default.
• W2004733105 citedByCount "28" @default.
• W2004733105 countsByYear W20047331052012 @default.
• W2004733105 countsByYear W20047331052013 @default.
• W2004733105 countsByYear W20047331052014 @default.
• W2004733105 countsByYear W20047331052016 @default.
• W2004733105 countsByYear W20047331052018 @default.
• W2004733105 countsByYear W20047331052019 @default.
• W2004733105 countsByYear W20047331052021 @default.
• W2004733105 crossrefType "journal-article" @default.
• W2004733105 hasAuthorship W2004733105A5025256830 @default.
• W2004733105 hasAuthorship W2004733105A5026845056 @default.
• W2004733105 hasAuthorship W2004733105A5083574960 @default.
• W2004733105 hasConcept C142724271 @default.
• W2004733105 hasConcept C178790620 @default.
• W2004733105 hasConcept C181199279 @default.
• W2004733105 hasConcept C185592680 @default.
• W2004733105 hasConcept C197957613 @default.
• W2004733105 hasConcept C202751555 @default.
• W2004733105 hasConcept C204787440 @default.
• W2004733105 hasConcept C2776120743 @default.
• W2004733105 hasConcept C2776910235 @default.
• W2004733105 hasConcept C2778627024 @default.
• W2004733105 hasConcept C29730261 @default.
• W2004733105 hasConcept C55493867 @default.
• W2004733105 hasConcept C71240020 @default.
• W2004733105 hasConcept C71924100 @default.
• W2004733105 hasConceptScore W2004733105C142724271 @default.
• W2004733105 hasConceptScore W2004733105C178790620 @default.
• W2004733105 hasConceptScore W2004733105C181199279 @default.
• W2004733105 hasConceptScore W2004733105C185592680 @default.
• W2004733105 hasConceptScore W2004733105C197957613 @default.
• W2004733105 hasConceptScore W2004733105C202751555 @default.
• W2004733105 hasConceptScore W2004733105C204787440 @default.
• W2004733105 hasConceptScore W2004733105C2776120743 @default.
• W2004733105 hasConceptScore W2004733105C2776910235 @default.
• W2004733105 hasConceptScore W2004733105C2778627024 @default.
• W2004733105 hasConceptScore W2004733105C29730261 @default.
• W2004733105 hasConceptScore W2004733105C55493867 @default.
• W2004733105 hasConceptScore W2004733105C71240020 @default.
• W2004733105 hasConceptScore W2004733105C71924100 @default.
• W2004733105 hasIssue "2-3" @default.

• next